A Phase I, Single Ascending Dose Trial to Examine the Safety and Pharmacodynamic Effects of CD-NP
Phase of Trial: Phase I
Latest Information Update: 01 Jun 2009
At a glance
- Drugs Cenderitide (Primary)
- Indications Heart failure
- Focus Adverse reactions; Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 01 Jun 2009 Pharmacodynamic results published in Journal of Clinical Pharmacology.
- 29 Aug 2007 New trial record.